1982
DOI: 10.1021/jf00112a048
|View full text |Cite
|
Sign up to set email alerts
|

Reinvestigation of the alkaloids of Lupinus sericeus Pursh. Identification of a new natural product, 10,17-dioxo-.beta.-isosparteine

Abstract: 0 5 10 15 20 25 TIME HOURSFigure 4. Rate of reaction of nifluridide at pH 9.0 with the formation of EL-919.balance was obtained by adding together the concentrations of nifluridide and EL-919 (as its nifluridide molecular weight equivalent). RESULTS AND DISCUSSIONThe rapid conversion of nifluridide to EL-919 proceeds as indicated in Figure 1. The rates of disappearance and the corresponding formation of EL-919 are plotted on a semilogarithmic scale in Figures 2-4. The cyclization proceeded via a first-order re… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

1982
1982
2017
2017

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 11 publications
0
1
0
Order By: Relevance
“… The enantiomers of sparteine are valued by organic chemists for a diversity of applications as chiral diamines in asymmetric synthesis, although supply issues have stimulated interest in the development of surrogates. , Reported bioactivity is also dominated by the more available stereoisomer, and (−)-sparteine even found clinical applications, for example as an oxytocic agent, , although its FDA approved drug status was withdrawn due to safety concerns. Comparatively less is known about the more scarce C 2 symmetrical isomers in terms of either pharmacology or synthetic applications as ligands. , There have been racemic total syntheses of α- and β-isosparteine, and enantiomerically enriched α- and β-stereoisomers have been obtained from synthetic conversions of other sparteine alkaloids. …”
mentioning
confidence: 99%
“… The enantiomers of sparteine are valued by organic chemists for a diversity of applications as chiral diamines in asymmetric synthesis, although supply issues have stimulated interest in the development of surrogates. , Reported bioactivity is also dominated by the more available stereoisomer, and (−)-sparteine even found clinical applications, for example as an oxytocic agent, , although its FDA approved drug status was withdrawn due to safety concerns. Comparatively less is known about the more scarce C 2 symmetrical isomers in terms of either pharmacology or synthetic applications as ligands. , There have been racemic total syntheses of α- and β-isosparteine, and enantiomerically enriched α- and β-stereoisomers have been obtained from synthetic conversions of other sparteine alkaloids. …”
mentioning
confidence: 99%